Bryan Johnson, the 47-year-old US tech entrepreneur who reportedly spends $2 million a year on his own anti-aging experiment, has become a polarizing figure in the longevity community. This piece is not a personal critique of Mr. Johnson. It is an attempt to audit the 100+ interventions inside the Blueprint protocol he openly publishes, scoring each at evidence Levels 1–4. We hold deep respect for his transparency and the courage required to run a public experiment on his own body. Our goal is to give readers a clear basis for deciding which parts to adopt, which to watch, and which to set aside.
Conclusion: Blueprint is a Level 1–4 mix. The core deserves serious consideration; the experimental edges remain N=1.
[Mix of Levels 1–4] [Lifestyle + Supplements + Experimental] [Core strongly worth borrowing / Experimental tier requires caution]
The Blueprint core — exercise, sleep, diet, basic supplements — rests on well-established Level 1–2 evidence and is broadly useful to most adults. The experimental layers Mr. Johnson is best known for — young plasma transfusion, full-body photobiomodulation, exploratory gene therapy attempts — sit at Level 3–4 in humans. Mr. Johnson himself has been transparent about this: “I run experiments on my own body, gather safety and efficacy data, and share them with the world” is the project’s stated purpose. The wise reader separates the “borrow” layer from the “observe” layer.
👤 About Bryan Johnson and Project Blueprint
Mr. Johnson sold his payments startup Braintree (parent of Venmo) to PayPal for $800 million in 2013. He has invested significant resources from that exit into anti-aging science, launching Project Blueprint in 2021.
Blueprint has three defining features:
- Fully open protocol: detailed procedures, supplement lists, blood markers, MRI scans, body composition, and outcome data published openly at blueprint.bryanjohnson.com. This is rare in health and wellness.
- Rigorous measurement: continuous tracking of 100+ blood markers, whole-body MRI, body composition, HRV, sleep, and cognitive testing — at significant cost.
- Self-experiment with collaborators: works with physicians (Dr. Oliver Zolman and others) toward publishable methodology.
In 2024 he launched the “Don’t Die” movement; Netflix released a documentary of the same name in 2025. Regardless of evidence-base disputes, Mr. Johnson has materially raised the public profile of healthspan science.
📋 Auditing Blueprint by Component
1. Diet (Level 1–2 — recommended)
- 2,250 kcal/day, plant-forward, zero ultra-processed food: essentially the Mediterranean/DASH direction → Level 1
- First meal in the morning, last meal around 11 a.m.: a form of time-restricted eating. Modest metabolic improvement evidence → Level 2
- Heavy use of nuts, olive oil, dark leafy greens, berries: each independently Level 1–2
2. Exercise (Level 1)
- ~1 hour per day combining aerobic, strength, and mobility. That exercise extends healthspan is Level 1.
- Frequency, intensity, and consistency exceed typical recommendations.
3. Sleep (Level 1)
- 20:30 lights-out, 5:30 wake-up (9 hours). Light, temperature, caffeine, and social-schedule control are tight.
- Sleep quality–healthspan linkage is Level 1. The extreme early-bird schedule is somewhat chronotype-dependent.
4. Core supplements (Level 2–3)
- Omega-3, vitamin D, magnesium: basic micronutrients → Level 2
- Metformin (prescription): off-label longevity use. TAME trial ongoing → currently Level 3
- Rapamycin (prescription): mTOR inhibitor with clear rodent lifespan extension (Level 1 in animals); in humans Level 3–4
- NMN / NR / NAD+ precursors: see our NMN feature. Safety Level 1, efficacy Level 2–3
- 100+ other supplements: mixed — most are individually Level 2–4
5. Testing & monitoring (Level 2)
- Regular blood, MRI, echocardiography: early detection is valuable
- “Over-testing” can produce false-positive stress (especially in cancer screening contexts)
6. Experimental interventions (Level 3–4)
- Young plasma transfusion (briefly trialed with his son’s blood, then discontinued): Conboy et al.’s mouse work is famous, but human lifespan benefit is not established. Mr. Johnson himself judged the data negative and stopped.
- Whole-body red-light therapy (PBM): skin/joint effects Level 2; broad anti-aging claims Level 3–4.
- Sound, electrical stimulation, various cosmetic procedures: variable per intervention.
- Stem cell and gene-therapy trials: frontier medicine. Level 4 (no human long-term data).
💪 What’s Worth Appreciating
Aside from the evidence question, Mr. Johnson’s approach has several genuine virtues:
- Complete transparency: full protocol, data, side effects, and failures published. The opposite stance of typical health influencers and supplement companies.
- Anti–bad-habit messaging: “Don’t Die” speaks to young men in particular about the classic combination of poor sleep, irregular eating, and inactivity.
- Self-funded science: pushing toward publishable methodology with personal money is a contribution to the field.
- Mainstreaming measurement: regular bloodwork, MRI, and body composition have become more normalized partly because of this project.
These overlap with evidage’s editorial commitments (independence, evidence, measurement).
⚠️ Before You Borrow From It
1. The budget gap is enormous
Mr. Johnson reportedly spends roughly $2M/year. Copying Blueprint literally is not realistic for almost anyone. “Cherry-picking the showy parts while skipping the core” is a real trap — flashy supplements without the underlying exercise/sleep/diet stack are mostly ornamental.
2. N=1 has structural limits
His protocol may fit his particular genetics, metabolism, and age — and not necessarily yours. Proper population-level inference still requires multi-thousand-participant RCTs that no individual can run alone. This is not criticism — it is the structural limit of N=1 experimentation.
3. Off-label prescription drugs need medical oversight
Rapamycin and metformin for longevity are popular, but long-term safety in healthy adults is not established. Watch for immune suppression (rapamycin) and B12 deficiency (metformin).
4. “Over-optimization” can crowd out the life
20:30 bedtime, 2,250 kcal/day, and 100+ supplement management may be hard to combine with social life, family time, and professional flexibility. If “Don’t Die” becomes “Don’t Live,” the trade-off is wrong.
5. “Epigenetic age reversal” claims need careful reading
DNA-methylation age has multiple measurement methods and results vary substantially between them. “Epigenetic age dropped 10 years” is a method-dependent number, not necessarily a guarantee of biological rejuvenation.
🎯 What to Borrow vs. Observe
Ordered by evidence-to-cost ratio, what most readers should consider borrowing:
- Consistent sleep schedule (same bed/wake time daily) ← Level 1, zero cost, largest effect
- 60+ minutes daily exercise (aerobic + resistance) ← Level 1, minimal cost
- Mediterranean / plant-forward / no ultra-processed food ← Level 1
- Regular blood work and physicals ← Level 2, often insurance-covered
- Reasonable omega-3 and vitamin D (if deficient) ← Level 2
- Measurement habit (weight, sleep, steps — smartwatch is enough) ← Level 2
Observe, do not yet copy:
- The 100-supplement stack — most are Level 3–4
- Off-label prescription drugs — careful physician conversation required
- Stem cell and gene therapy — observation only
- Red-light therapy and stim devices — evidence is narrow
📝 Summary
- Mr. Johnson’s Blueprint has historical importance in mainstreaming longevity science.
- The protocol is a mix of Levels 1–4. The core is strongly worth borrowing.
- The experimental interventions are worth “watching” but not yet “copying.”
- Borrowing surface details without the core delivers lower ROI than perfecting the core alone.
- The most transferable thing about Blueprint is the culture of measuring, sharing, and discussing your own data.
📚 References
- Johnson B. Blueprint Protocol (open protocol). blueprint.bryanjohnson.com
- Conboy IM, et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433:760–764.
- Mannick JB, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med. 2014;6(268).
- Barzilai N, et al. Metformin as a Tool to Target Aging (TAME). Cell Metab. 2016;23(6):1060–1065.
- “Don’t Die” documentary, Netflix, 2025.
⚠️ Disclaimer
- This article does not evaluate Mr. Johnson personally — it evaluates the openly published Blueprint protocol’s components on evidence grounds.
- Any intervention involving prescription drugs requires consultation with a physician.
- Information current as of May 2026.
